Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
British Journal of Clinical Pharmacology|December 23, 2025
Model-informed precision dosing of carboplatin in cancer patients by leveraging myelosuppression data from electronic health recordsAlessandro De Carlo, Elena Maria Tosca, Mirjam Crul, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balanceTanja D de Gruijl, Claudia C Sombroek, Sinéad M Lougheed, et al.Oral Oncology|March 15, 2006
Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experienceRemco de Bree, Paul van der Valk, Dirk J Kuik, et al.Neuroradiology|July 15, 2011
MRI and thallium-201 SPECT in the prediction of survival in gliomaMaaike J Vos, Johannes Berkhof, Otto S Hoekstra, et al.Head & Neck|March 3, 2015
Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancerJolien Heukelom, Marta Lopez-Yurda, Alfons J M Balm, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2014
The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort studyIrma M Verdonck-de Leeuw, Laurien M Buffart, Martijn W Heymans, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 16, 2015
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the NetherlandsNaomi van der Linden, Jan Buter, Chris P Pescott, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 8, 2012
Computerized monitoring of patient-reported speech and swallowing problems in head and neck cancer patients in clinical practiceIngrid C Cnossen, Remco de Bree, Rico N P M Rinkel, et al.Neuro-Oncology|February 17, 2017
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trialRenske Gahrmann, Martin van den Bent, Bronno van der Holt, et al.Neuro-Oncology Advances|April 14, 2022
The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumabRenske Gahrmann, Marion Smits, René Michel Vernhout, et al.Pageof 4